Harmony Biosciences Holdings, Inc. HRMY Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s return on invested capital?
- Harmony Biosciences Holdings, Inc. (HRMY) reported return on invested capital of 31.2% in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s return on invested capital changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s return on invested capital decreased by 18.9% year-over-year, from 38.5% to 31.2%.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s return on invested capital?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s return on invested capital has grown at a -12.2% compound annual growth rate (CAGR), from 76.8% to 45.6%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.